NCT07570407
- Conditions
- Acute Myeloid Leukemia, Allogeneic HSCT, Disease Attributes, +13 more
- Locations
-
- University Hospital Pilsen Pilsen, Czechia
Clinical trial condition
Relapse
Explore clinical trials studying Relapse. Study availability and eligibility vary by location and protocol.
59 public trials
19 recruiting studies
Relapse trial results
NCT06090864
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
NCT06347068
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- University of North Carolina Chapel Hill, North Carolina, United States
NCT06096038
- Conditions
- Disease Attributes, Head and Neck Cancer, Head and Neck Neoplasms, +8 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States
NCT06618755
- Conditions
- Addiction, Alcohol Use Disorder, Alcohol Withdrawal, +15 more
- Locations
-
- Thomas RISDORFER DE ISSDENTZI Montpellier, France
NCT06158139
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, +12 more
- Locations
-
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
NCT07622277
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- Dr.Manisha Rohtak, Haryana, India
NCT07611838
- Conditions
- Allergic Bronchopulmonary Aspergillosis (ABPA), Aspergillosis, Aspergillosis, Allergic Bronchopulmonary, +20 more
- Locations
-
- Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China, Jinan, Shandong 250014 Jinan, Shandong, China
NCT07604909
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +14 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Recruiting
Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
NCT06919939
- Conditions
- Disease Attributes, Large B-cell Lymphoma, Pathologic Processes, +3 more
- Locations
-
- University of Miami Miami, Florida, United States